Unconfigured Ad
Collapse
Bridged amplification & clustering followed by sequencing by synthesis.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by PaulineF, 02-08-2010, 04:22 PM
|
2 responses
3,011 views
0 reactions
|
Last Post
by PaulineF
02-09-2010, 12:10 PM
|
||
|
Started by RockChalkJayhawk, 08-19-2009, 06:28 AM
|
3 responses
5,866 views
0 reactions
|
Last Post
|
||
|
Started by para_seq, 01-21-2010, 09:11 AM
|
1 response
2,854 views
0 reactions
|
Last Post
by Torst
02-07-2010, 03:46 PM
|
||
|
Started by johannes.rainer, 02-05-2010, 07:50 AM
|
0 responses
3,528 views
0 reactions
|
Last Post
|
||
|
Started by ECHo, 02-02-2010, 02:00 AM
|
0 responses
1,699 views
0 reactions
|
Last Post
by ECHo
02-02-2010, 02:00 AM
|
||
|
Started by kbushley, 01-19-2010, 10:55 AM
|
6 responses
5,502 views
0 reactions
|
Last Post
by shurjo
01-31-2010, 05:49 PM
|
||
|
Started by rainbow, 01-29-2010, 01:39 AM
|
1 response
8,627 views
0 reactions
|
Last Post
by lh3
01-29-2010, 04:59 AM
|
||
|
Started by Pepe, 08-19-2009, 10:35 AM
|
9 responses
86,721 views
0 reactions
|
Last Post
by seqgirl77
01-28-2010, 05:36 PM
|
||
|
Started by upenn_ngs, 01-28-2010, 07:10 AM
|
— | — | ||
|
Started by mingkunli, 01-20-2010, 03:34 PM
|
5 responses
9,587 views
0 reactions
|
Last Post
by mingkunli
01-27-2010, 12:35 PM
|
No topics found.
-
Page of 0
Posted Photos
1 Photo
Screenshot 2026-10-23 at 11.47.08 AM.png
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is changing how clinical and public health laboratories detect pathogens, track antimicrobial resistance,...-
Channel: Webinar Series
10-01-2026, 05:37 AM -
-
by SEQadmin2
Much of the genetic basis of Alzheimer's disease and related dementias (AD/ADRD) is still unexplained, and some of the answers may sit...-
Channel: Webinar Series
10-01-2026, 05:06 AM -
Recent Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
39 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
41 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|